Elevance Health, Inc. which can be found using ticker (ELV) have now 20 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 620 and 540 calculating the average target price we see $573.45. Given that the stocks previous close was at $456.78 and the analysts are correct then we can expect a percentage increase in value of 25.5%. Also worth taking note is the 50 day moving average now sits at $466.51 while the 200 day moving average is $485.90. The market cap for the company is 108.89B. The current share price for the company is: 457.46 USD
The potential market cap would be $136,704,384,251 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 17.73, revenue per share of 672.21 and a 5.39% return on assets.
